Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Retained Earnings

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Retained Earnings

NIAGEN BIOSCIENCE, INC. (NAGE) had Retained Earnings of -$157.25 million as of 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04

  • 2026-06-30: Retained Earnings (Accumulated Deficit) -$157.25M.
  • 2026-03-31: Retained Earnings (Accumulated Deficit) -$158.21M.
  • 2025-12-31: Retained Earnings (Accumulated Deficit) -$164.53M.
  • 2025-09-30: Retained Earnings (Accumulated Deficit) -$168.66M.
Period endRetained Earnings (Accumulated Deficit)Retained Earnings (Accumulated Deficit) as first filed
2026-06-30-$157.25M
10-Q · filed 2026-08-04
2026-03-31-$158.21M
10-Q · filed 2026-05-06
2025-12-31-$164.53M
10-Q · filed 2026-08-04
2025-09-30-$168.66M
10-Q · filed 2025-11-04
2025-06-30-$173.24M
10-Q · filed 2025-08-06
2025-03-31-$176.85M
10-Q · filed 2025-05-07
2024-12-31-$181.91M
10-K · filed 2026-03-04
2024-09-30-$189.09M
10-Q · filed 2024-10-31
2024-06-30-$190.97M
10-Q · filed 2024-08-07
2024-03-31-$190.95M
10-Q · filed 2024-05-08
2023-12-31-$190.46M
10-K · filed 2025-03-04
2023-09-30-$190.57M
10-Q · filed 2023-11-08
2023-06-30-$189.62M
10-Q · filed 2023-08-09
2023-03-31-$187.42M
10-Q · filed 2023-05-10
2022-12-31-$185.49M
10-K · filed 2024-03-06
2022-09-30-$184.07M
10-Q · filed 2022-11-02
2022-06-30-$183.09M
10-Q · filed 2022-08-10
2022-03-31-$176.69M
10-Q · filed 2022-05-12
2021-12-31-$168.95M
10-K · filed 2023-03-08
2021-09-30-$163.63M
10-Q · filed 2021-11-03
2021-06-30-$154.77M
10-Q · filed 2021-08-03
2021-03-31-$149.21M
10-Q · filed 2021-05-06
2020-12-31-$141.82M
10-K · filed 2022-03-14
2020-09-30-$135.73M
10-Q · filed 2020-11-04
2020-06-30-$131.51M
10-Q · filed 2020-08-06
2020-03-31-$127.80M
10-Q · filed 2020-05-18
2019-12-31-$121.90M
10-K · filed 2021-03-12
2019-09-30-$113.05M
10-Q · filed 2019-11-12
2019-06-30-$105.84M
10-Q · filed 2019-08-07
2019-03-31-$98.09M
10-Q · filed 2019-05-09
2018-12-31-$89.75M
10-K · filed 2020-03-10
2018-09-30-$81.53M
10-Q · filed 2018-11-07
2018-06-30-$72.93M
10-Q · filed 2018-08-09
2018-03-31-$64.88M
10-Q · filed 2018-05-10
2017-12-30-$56.60M
10-K · filed 2019-03-07
-$56.60M
10-K · filed 2018-03-15
2017-09-30-$47.78M
10-Q · filed 2017-11-09
2017-07-01-$49.92M
10-Q · filed 2017-08-10
2017-04-01-$47.15M
10-Q · filed 2017-05-11
2016-12-31-$45.22M
10-K · filed 2018-03-15
2016-10-01-$43.08M
10-Q · filed 2016-11-10
2016-07-02-$42.12M
10-Q · filed 2016-08-11
2016-04-02-$42.04M
10-Q · filed 2016-05-12
2016-01-02-$42.30M
10-K · filed 2017-03-16
2015-10-03-$40.87M
10-Q · filed 2015-11-12
2015-07-04-$40.87M
10-Q · filed 2015-08-13
2015-04-04-$40.55M
10-Q · filed 2015-05-14
2015-01-03-$39.52M
10-K · filed 2016-03-17
-$39.52M
10-K · filed 2015-03-19
2014-09-27-$38.30M
10-Q · filed 2014-11-06
2014-06-28-$37.64M
10-Q · filed 2014-08-12
2014-03-29-$35.98M
10-Q · filed 2014-05-08
2013-12-28-$34.14M
10-K · filed 2015-03-19
2013-09-28-$33.41M
10-Q · filed 2013-11-21
2013-06-29-$32.16M
10-Q/A · filed 2013-12-05
-$29.24M
10-Q · filed 2013-08-13
2013-03-30-$31.14M
10-Q/A · filed 2013-12-05
-$28.25M
10-Q · filed 2013-05-10
2012-12-29-$29.72M
10-K · filed 2014-03-27
2012-09-29-$28.02M
10-Q · filed 2012-11-08
2012-06-30-$26.48M
10-Q/A · filed 2012-08-10
2012-03-31-$22.49M
10-Q · filed 2012-05-10
2011-12-31-$18.05M
10-K · filed 2013-03-29
2011-10-01-$15.56M
10-Q · filed 2011-11-10
2011-07-02-$13.16M
10-Q · filed 2011-08-11
2011-01-01-$10.16M
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87